The efficacy and safety of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis based on randomized controlled trials

The efficacy and safety of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis based on randomized controlled trials

BackgroundCabazitaxel (CAB) has been approved for the treatment of patients with progressed metastatic castration-resistant prostate cancer (mCRPC) after receiving docetaxel. To assess the efficacy and safety of CAB in mCRPC patients through systematic review and network meta-analysis.MethodsRandomi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Cong Shao, Quan Wan, Jia Guo, Zhuo Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pharmacology
Subjects:	prostate cancer castration resistance cabazitaxel meta-analysis systematic review
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1586650/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01)

Clinical observations of patients with metastatic castration-resistant prostate cancer living in the Tambov region
by: P. G. Berezin, et al.
Published: (2023-09-01)

Role of exosomes in castration-resistant prostate cancer
by: Yuan Cao, et al.
Published: (2025-05-01)

Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer
by: Marina N. Sharifi, et al.
Published: (2025-08-01)

Screening and validation of key genes involved in castration-resistant prostate cancer based on transcriptomics sequencing
by: Guangquan Tong, et al.
Published: (2025-07-01)

Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
by: Himisha Beltran, et al.
Published: (2025-08-01)

Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (CRPC) Patients: CaPA Study
by: Pedro Costa, et al.
Published: (2025-08-01)

Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway
by: Wen Zhang, et al.
Published: (2021-11-01)

Wnt5a augments intracellular free cholesterol levels and promotes castration resistance in prostate cancer
by: Yuqi Guo, et al.
Published: (2025-03-01)

A Super‐Enhancer‐Driven Transcriptional Regulatory Circuit Underlying Abiraterone Resistance in Castration‐Resistant Prostate Cancer
by: Liling Jiang, et al.
Published: (2025-08-01)

Targeting the adaptive molecular landscape of castration‐resistant prostate cancer
by: Alexander W Wyatt, et al.
Published: (2015-04-01)

Androgen receptor as a potential therapeutic target in castration-resistant prostate cancer: a bibliometric analysis (2005–2024)
by: Jiexiang Zhang, et al.
Published: (2025-07-01)

A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
by: Xiaolin Lu, et al.
Published: (2025-05-01)

USE OF <sup>177</sup>Lu-PSMA FOR RADIONUCLIDE THERAPY IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER
by: A. A. Medvedeva, et al.
Published: (2021-06-01)

Combinatorial Effects of Free and Nanoencapsulated Forms of Cabazitaxel and RAS-Selective Lethal 3 in Breast Cancer Cells
by: Remya Valsalakumari, et al.
Published: (2025-05-01)

Therapeutic outcomes of enzalutamide-docetaxel combination versus docetaxel monotherapy in post-sequential androgen receptor axis-targeted therapy failure metastatic castration-resistant prostate cancer
by: Zhiyu Zhang, et al.
Published: (2025-08-01)

Metastasis directed radiotherapy versus standard of care for PSMA-PET diagnosed oligometastatic/oligoprogressive castration resistant prostate cancer
by: Laura Bauersachs, et al.
Published: (2025-07-01)

<sup>225</sup>Aс-PSMA-617 therapy in metastatic castration-resistant prostate cancer
by: T. Yu. Kochetova, et al.
Published: (2025-01-01)

Serum CDC42 level change during abiraterone plus prednisone treatment and its association with prognosis in metastatic castration-resistant prostate cancer patients
by: Yong Ma, et al.
Published: (2025-03-01)

Intravenous radionuclide therapy with radium chloride [223Ra] in patients with bone metastases from castration-resistant prostate cancer
by: O. I. Kit, et al.
Published: (2024-12-01)

Single-cell sequencing unveils the transcriptomic landscape of castration-resistant prostate cancer-associated fibroblasts and their association with prognosis and immunotherapy response
by: Yifeng Qiu, et al.
Published: (2025-04-01)

Rapid and sustainable deep testosterone reduction predicts effective androgen deprivation therapy for metastatic hormone-sensitive prostate cancer
by: Ze Wang, et al.
Published: (2025-08-01)

Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer
by: Zhongqiang Fan, et al.
Published: (2025-06-01)

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
by: Nader Al Nakouzi, et al.
Published: (2016-05-01)

Safety profile and dose-dependent adverse events of upadacitinib in randomized clinical trials: a systematic review and meta-analysis
by: Cong Zhang, et al.
Published: (2025-06-01)

DEGARELIX ROLE AND PLACE IN THE COMBINED TREATMENT OF PATIENTS WITH PROSTATE CANCER IN COMBINATION WITH CONCURRENT RADIOTHERAPY
by: A. Y. Pavlov, et al.
Published: (2016-02-01)

Philosophical Foundation of Chemical Castration for Offenders of Sexual Violence Against Children
by: Henny Yuningsih, et al.
Published: (2020-01-01)

Ratio Legis of Chemical Castration to the Perpetrators of Sexual Violence against Children
by: Henny Yuningsih
Published: (2020-07-01)

The efficacy of Chinese herbal medicine on anxiety and depression in patients with chronic prostatitis complicated by sexual dysfunction: a systematic review and meta-analysis protocol
by: Zhaozhan Xie, et al.
Published: (2025-08-01)

Effect of castration and days on feed on body composition, glucose tolerance, and muscle gene expression in Nellore cattle
by: Luiz Henrique Pereira Silva, et al.
Published: (2025-08-01)

Experience and needs of stroke patients in physical rehabilitation: a systematic review and meta-synthesis
by: Xueting Sun, et al.
Published: (2025-08-01)

Efficacy and safety of tacrolimus in the treatment of Henoch-Schönlein purpura nephritis: systematic review and meta-analysis
by: Tong Xie, et al.
Published: (2025-08-01)

Systematic review and meta-analysis on the efficacy and safety of acupuncture for perimenopausal insomnia
by: ShiWei Song, et al.
Published: (2025-08-01)

Identification of a ferroptosis related genes signature and GDF15 contributing to a new perspective for the diagnosis of CRPC
by: Yuanyuan Shao, et al.
Published: (2025-07-01)

Unlocking the Role of OCT4 in Cancer Lineage Plasticity: A Cross-Cancer Perspective with an Emphasis on Prostate Cancer
by: Mohammad Esfini Farahani, et al.
Published: (2025-07-01)

SYSTEMATIC REVIEW AND META-ANALYSIS: PITFALLS OF METHODS
by: Yu. V. Lukina, et al.
Published: (2016-05-01)

Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer
by: N. A. Avxentyev, et al.
Published: (2019-01-01)

Effectiveness and safety of acupuncture and related therapies for pediatric asthma: a systematic review and meta-analysis
by: Jixuan Wang, et al.
Published: (2025-07-01)

Critical Factors Affecting Construction Labor Productivity: A Systematic Review and Meta-Analysis
by: Feihong Jian, et al.
Published: (2025-07-01)

The association between alcohol and metabolic syndrome: a systematic review and meta-analysis
by: Maedeh Arshadi, et al.
Published: (2025-07-01)